Medial artery calcification is a common macroangiopathy that initiates from a cell-regulated process similar to osteogenesis. Although the mechanisms governing this process remain unclear, epigenomic regulation by specific microRNAs might play a role in vascular smooth muscle cell (VSMC) calcification. In this study, we aimed to investigate whether miR-204 participates in the regulation of VSMC calcification.
Introduction
Medial artery calcification, such as coronary artery and peripheral artery calcification, is becoming an increasingly common and serious problem with ageing of the population. It decreases vessel elasticity, augments pulse pressure, and is associated with increased incidence of many cardiovascular diseases, such as myocardial infarction, hypertension, and increased plaque rupture during angioplasty procedures. 1 -4 Previously, vascular calcification was considered to be a passive precipitation of calcium phosphate mineral in necrotic tissue. However, recently, many researchers have recognized the participation of cellular activities in this process. The main feature of this process is characterized by apatite deposition on collagen fibrils and the presence of matrix vesicles, 5 which is similar to those of bone mineralization. The predominant cells in the tunica media of arteriesvascular smooth muscle cells (VSMCs)-acquire an osteogenic phenotype as indicated by increased expression of core-binding factor a1 (Cbfa1, Runx2), osteopontin, osteocalcin, and alkaline phosphatase (ALP). 5, 6 This proves medial artery calcification to be an actively regulated process of osteoblastic differentiation of VSMCs. However, the specific pathways governing this active process is still unknown. In recent years, microRNAs (miRNAs, miRs) have become recognized as being one of the most important gene regulators of widespread cellular functions such as proliferation, differentiation, migration, and apoptosis. 7 They are a growing class of small (16 25 nucleotides), single-stranded non-coding RNAs that regulate translation of specific mRNAs by induction of mRNA degradation or blockage of translation. 8, 9 An miRNA often targets tens and hundreds of genes, providing extensive transcriptional regulation, which can be controlled by individual miRNAs or miRNAs acting in concert. 10 There has been evidence that a series of specific miRNAs play critical roles in the regulation of vascular cell functions and contribute to various pathological conditions such as atherosclerosis, pulmonary arterial hypertension, and neointimal lesion formation after vascular injury. 11 -14 However, the effect of the specific miRNAs and the mechanisms by which these miRNAs target gene expression in VSMC calcification still need to be validated. miR-204 is encoded within the TRPM3 gene and is expressed in arterial smooth muscle cells and cardiomyocytes in the cardiovascular system. 15, 16 In the study of Huang et al., 17 miR-204 inhibits osteoblastic differentiation and promotes the adipogenesis of mesenchymal progenitor cells and bone marrow stromal cells through down-regulating the key transcription factor for osteogenesis-Runx2, indicating its critical role in osteogenesis. However, it is unknown whether miR-204 exerts any effect on calcification of VSMCs. In addition, it remains unclear whether VSMC calcification that occurs in the tunica media can be prevented by pharmacological interventions. The objective of this study was to elucidate the effect of miR-204 on regulation of VSMC calcification in vitro and in vivo and to investigate its underlying mechanisms.
Methods

Ethics statement
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (NIH publication no. 85 -23, revised 1996). Approval was granted by the Second Xiangya Hospital of Central South University Ethics Review Board.
Reagents
Pentobarbital sodium, b-glycerophosphate, vitamin D3 (cholecalciferol), and Dulbecco's modified Eagle's medium (DMEM) were purchased from Sigma (St Louis, MO, USA). Foetal bovine serum was purchased from Gibco-BRL Corp. (Grand Island, NY, USA). Maxima SYBR Green/ROX qPCR Master Mix (2×) was purchased from Fermentas, Inc. (Berlington, Ontario, Canada). Lipofectamine 2000 was purchased from Invitrogen Corp. (Carlsbad, CA, USA). Antibodies for Runx2 and b-actin, HRP-conjugated goat-anti-rabbit secondary antibody, and the ECL detection kit were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). MiR-204 mimics and miR-204 inhibitors (2 ′ -O-methyl modified) and their control oligos were purchased from Ribobio (Guangzhou, China). Runx2 siRNA oligos and control siRNA oligos were purchased from Qiagen (Hilden, Germany).
Cell culture and transfection
To isolate primary cells, 8-week-old female Kunming mice were given ip injection of pentobarbital sodium (150 mg/kg) before death, which was confirmed by the absence of a heartbeat. Primary mouse aortic smooth muscle cells were isolated as described previously. 18 The VSMC phenotype was confirmed by positive immunostaining of a-smooth muscle actin. VSMCs were cultured in DMEM (with glutaMAX) supplemented with 15% foetal bovine serum. To induce calcification, 100% confluent VSMCs with passage 3 -7 were cultured in DMEM supplemented with 10 mM b-glycerophosphate. 19 The transformation to calcified cells was 
Measurements of alkaline phosphatase activity and osteocalcin secretion
Confluent mice VSMCs were washed with PBS, and the cell layers were scraped into solution containing 20 mM Tris -HCl (pH 8.0), 150 mM NaCl, 1% Triton X-100, 0.02% NaN 3 , and 1 mg/mL aprotinin. The lysates were homogenized and assayed for ALP activity by measuring r-nitrophenol release at 378C using spectrophotometry. Protein expression was normalized to total cellular protein by the Bradford protein assay.
Osteocalcin secretion into the culture media was measured with a radioimmunoassay kit (DiaSorin Corp., Stillwater, MN, USA) according to the manufacturer's instructions. Protein expression was normalized to total cellular protein by the Bradford protein assay.
Quantitative reverse transcription-polymerase chain reaction
Total RNA was extracted using the mirVana miRNA Isolation Kit (Ambion). For analysis of miR-204 expression, reverse transcription and quantitative reverse transcription-polymerase chain reaction (qRT -PCR) were carried out using Bulge-LoopTM miRNA qPCR Primer Set for mice miR-204 (RiboBio, MQP-0101) and U6 snRNA (RiboBio, MQP-0201) according to the manufacturer's instructions. Expression of Runx2 and that of GAPDH mRNA were also measured by qRT -PCR amplification. Primer sequences for mouse Runx2 and GAPDH are presented in Table 1 . Expression of miR-204 relative to U6 and that of Runx2 relative to GAPDH were determined using the 2 2DDCT method.
Western blot analysis
Western blot analysis was carried out for detection of Runx2 or actin protein levels as previously described. 20, 21 Ten micrograms of protein and 4 mL of 5× protein loading buffer were used for each western blot performed. The ECL detection kit was used for detection.
Luciferase reporter assay
Mice VSMCs were cotransfected with a luciferase reporter carrying wildtype Runx2 3 ′ -UTR (WT-pGL3-Runx2) or mutant Runx2 3 ′ -UTR (MUT-pGL3-Runx2) and miR-204 mimics or control oligos (miR-C). Forty-eight hours after transfection, luciferase activities were detected with the luciferase assay system (Promega).
Runx2 has a long 3 ′ -UTR of 4 kb, which might contain multiple binding sites for miR-204 interaction. ,1952-1958) , and m2 (T3,3067-3073) separately, cotransfected them with miR-204 mimics or control oligos in mice VSMCs, and compared the luciferase activity in each group. To construct WT-pGL3-Runx2, a segment of mouse Runx2 was amplified from mouse genomic DNA and inserted into the XbaI-FseI site in the pGL3-Control Firefly Luciferase reporter vector. To construct MUT-pGL3-Runx2, the QuickChange site-directed mutagenesis kit (Stratagene) was used to induce three point mutations in the UTR region of WT-pGL3-Runx2. Plasmid DNA was sequenced for authenticity. The sequences of the PCR and mutagenic primers are shown in Table 2 .
Mice
Cholesterol-conjugated miR-204 agomirs (agomir-204) and negative control were from Ribobio (Guangzhou, China). Twenty-four 6-weekold female Kunming mice were randomly divided into three groups: vitamin D 3 + vehicle (n ¼ 8), vitamin D 3 + agomir-204 (n ¼ 8), and control (n ¼ 8) group. The mice in vitamin D 3 + vehicle group were given subcutaneous injections of vitamin D 3 at a dose of 500 000 IU/kg body weight and vehicle on Days 1 -3 to induce soft tissue calcification. 22 The mice in the vitamin D 3 + agomir-204 group received vitamin D 3 through subcutaneous injection and 80 mg/kg body weight of agomir-204 through tail vein injection on Days 1 -3. The mice in the control group received subcutaneous injections of 7% emulphor (vitamin D 3 stock solutions) 23 on Days 1 -3. Seven days after the first injection, the mice received ip injection of pentobarbital sodium (150 mg/kg) before death, which was confirmed by the absence of a heartbeat. The artery and bone samples were dissected from the mice. Measurement of miR-204 levels was performed by qRT -PCR and Runx2 protein levels by western blot analysis in aorta tissue. Part of the artery samples were fixed in 4% paraformaldehyde for 24 h and embedded in paraffin. Von Kossa staining was used to detect medial artery calcification. Dried artery samples were decalcified with HCl. The calcium content in HCl supernatants was determined using the O-cresolphthalein Complexone method. Total protein was quantified using the Bradford protein assay. The calcium content was normalized with protein content and expressed as microgram calcium per milligram protein.
Bone mineral density measurement
The left femur of each mouse was placed on the scanning table along the longitudinal axis, and the whole femur was scanned by dual-energy X-ray absorptiometry (DXA) using a PIXImus densitometer (GE Lunar) to determine the bone mineral density (BMD). 24 
Micro-CT analysis
The right femur of each mouse was fixed with 4% paraformaldehyde for 24 h and then washed with 10% saccharose solution. Micro-CT scanning was performed using the GE explore Locus SP system. 25, 26 Structural parameters of the proximal femur, including the trabecular bone volume (BV/TV: %), thickness (Tb.Th: mm), trabecular number ), and trabecular bone separation (Tb.Sp: mm), were evaluated by micro-CT.
Statistical analysis
SPSS 13.0 for Windows (SPSS, Chicago, IL, USA) was used for all statistics. Data are presented as means + SD. Comparisons were made using a one-way ANOVA and the LSD post hoc test for multiple comparisons, and differences at P , 0.05 were considered statistically significant.
Results
Up-regulation of osteoblast-related genes during VSMC calcification
Calcification can be induced by the organic phosphate, b-glycerophosphate in VSMCs. 5 Increased bone matrix mineral deposition revealed by Alizarin Red S staining ( Figure 1A) , elevated ALP activity detected by the spectrophotometry assay ( Figure 1B) , and increased osteocalcin secretion by the radioimmunoassay ( Figure 1B) were induced when cells were cultured under calcification medium compared with those without calcification medium. Runx2 protein levels were significantly elevated by 14-day treatment of b-glycerophosphate ( Figure 1C ). This observation proved up-regulated Runx2 protein expression and increased osteogenic markers in the process of VSMC calcification.
To determine whether miR-204 is associated with VSMC calcification, total RNA was extracted for qRT-PCR analysis. The results showed that the expression of miR-204 was significantly decreased during VSMC calcification ( Figure 1D ). These results demonstrate that the expression of miR-204 is decreased, whereas Runx2 protein level is up-regulated during VSMC calcification, indicating that miR-204 might suppress Runx2 protein level in VSMC calcification.
Attenuation of Runx2 expression by miR-204
To investigate the effect of miR-204' on Runx2 protein levels, we transfected mice VSMCs with miR-204 mimics or inhibitors and their control, respectively. qRT-PCR results demonstrated significantly increased miR-204 levels in VSMCs transfected with miR-204 mimics and decreased miR-204 levels with miR-204 inhibitors (Figure 2A) . In VSMCs overexpressing miR-204, Runx2 protein levels were significantly inhibited, whereas in miR-204 inhibition cells, Runx2 protein levels were significantly up-regulated ( Figure 2B) . In contrast, miR-204 oligos transfection had no obvious effect on Runx2 mRNA expression ( Figure 2C) , suggesting that miR-204 attenuates protein translation of Runx2 in VSMCs. 
miR-204 directly targets Runx2 in VSMCs
Rna22 27 predicted one putative miR-204-binding site in the 3 ′ -UTR region of Runx2 (T1,5326-5333, Figure 3A ). To determine whether miR-204 can directly target Runx2, a luciferase reporter construct containing the wild-type or T1 mutant 3 ′ -UTR coding sequences for
Runx2 was generated and introduced with miR-204 mimics into mice VSMCs. Overexpression of miR-204 significantly repressed the luciferase activity of the WT-3 ′ -UTR of Runx2 reporter plasmids but not that of the T1 MUT-Runx2-3 ′ -UTR reporters ( Figure 3B ).
Control miR mimics did n'ot affect the wild-type or mutant constructs, confirming the specificity of the action. We next compared the luciferase activity of the T1 MUT -Runx2-3 ′ -UTR reporter with the T2 or T3 MUT-Runx2-3 ′ -UTR reporters. The results showed that all the three MUT-Runx2-3 ′ -UTR reporters had higher luciferase activity compared with the WT-Runx2-3 ′ -UTR reporter ( Figure 3C ).
The T1 MUT-Runx2-3 ′ -UTR reporter had the least response to the miR-204 mimics transfection, suggesting that the binding sites of T1 may play the key role in miR-204-regulated Runx2 protein levels in VSMCs.
miR-204 inhibits b-glycerophosphate-induced osteoblastic differentiation of VSMCs
Since miR-204 down-regulates Runx2 expression in VSMCs, we next investigate whether miR-204 has a regulatory effect on the osteoblastic differentiation of VSMCs. Two days after transfection with miR-204 mimics, miR-204 inhibitors, or control oligos, mice VSMCs were MicroRNA-204 regulates vascular smooth muscle cell calcification treated with 10 mM b-glycerophosphate for 4 days, and then tested for ALP activity and osteocalcin secretion, and harvested for Runx2 by western blot analysis. Overexpression of miR-204 significantly decreased ALP activity, osteocalcin secretion, and Runx2 protein levels, whereas inhibition of miR-204 resulted in enhanced ALP activity, osteocalcin secretion, and increased Runx2 protein levels ( Figure 4A and B) . These results indicate that miR-204 plays a negative role in VSMC calcification through down-regulating Runx2 protein levels.
To further investigate whether miR-204 relies on Runx2 to regulate osteoblastic differentiation of VSMCs, we evaluated the effect of Runx2 siRNA on the miR-204-regulated calcification process of mice VSMCs. Transfection of Runx2 siRNA significantly reduced ALP activity and osteocalcin secretion, whereas transfection of miR-204 inhibitors significantly increased them. Runx2 siRNA completely blocked the ALP activity and osteocalcin secretion induced by miR-204 inhibitors ( Figure 4C) , confirming the Runx2-dependent effect of miR-204 inhibitors on ALP activity and osteocalcin secretion. Treatment with Runx2 siRNA blocked the expression of Runx2 protein in mice VSMCs, whereas no blockage was observed upon treatment with the scramble Runx2 siRNA ( Figure 4D ).
miR-204 inhibits medial artery calcification in vivo
Von Kossa ( Figure 5A ) stained sections from vitamin D 3 + vehicletreated mice showed extensive calcification in the thoracic aorta media compared with those from the control group; however, calcification was alleviated in the aortas from the vitamin D 3 + agomir-204-treated mice. The calcium content in the aortas from the vitamin D 3 + agomir-204-treated mice also decreased relative to the vitamin D 3 + vehicle-treated mice, suggesting an inhibitory effect of miR-204 on vascular calcification. qRT -PCR revealed that miR-204 expression was slightly decreased in the aortas from the vitamin D 3 + vehicle-treated mice but significantly elevated in those from the vitamin D 3 + agomir-204-treated mice ( Figure 5B) . Western blot analysis showed that Runx2 protein levels were up-regulated in the aortas from the vitamin D 3 + vehicle-treated mice but down-regulated in those from the vitamin D 3 + agomir-204-treated mice ( Figure 5C ). These results collectively suggest that miR-204 inhibits medial artery calcification through down-regulating Runx2 protein in vivo.
miR-204 has no affect on bone formation in vivo
The Piximus DXA results showed no obvious difference in the femur BMD of mice in the control group, vitamin D 3 + vehicle-treated group and vitamin D 3 + agomir-204-treated group ( Figure 6A) .
Calculations of the BV/tissue volume (TV) ratio, trabecular number, trabecular spacing, and trabecular thickness of the proximal femur of mice in each group were performed using micro-CT ( Figure 6B) . The assay revealed no obvious difference in bone parameters between the groups. These results revealed that neither 
Discussion
In this study, we identified miR-204 as a negative regulator of VSMC calcification that functions through repressing Runx2 expression.
To date, there are 1527 human miRNAs and 741 mouse miRNAs registered in the miRBase (http://www.mirbase.org/). 28 -30 However, thousands of miRNAs in various genomes and their targets still need to be validated. 29 Recent discoveries of miRNAs expressed in
VSMCs have disclosed their important roles in regulation of proliferation, differentiation, apoptosis, and calcification. 12, 31, 32 But the function of miRNAs in medial artery calcification has not been thoroughly investigated. We have focused on the influence of miRNAs in VSMC calcification, which is critical to a variety of cardiovascular pathologies. In the study of Courboulin et al'., 13 miR-204 targets SHP2 expression in pulmonary artery smooth muscle cells (PASMCs), stimulates proliferation, and inhibits apoptosis of PASMCs, and is closely associated with the severity of pulmonary arterial hypertension. Another study in retinal epithelial cells has demonstrated that the down-regulation of miR-204 leads to enhanced PDGFb expression, increased cell proliferation, and down-regulation of K + channels, which depolarizes epithelial cell membrane potential. 33 Here, we identifies the expression of miR-204' in mice VSMCs and demonstrated that its expression was significantly decreased during b-glycerophosphate-induced VSMC calcification, indicating that miR-204 might play a role in vascular calcification.
To prove whether miR-204 is directly associated with VSMC calcification, we investigated the effect of miR-204 in the process of MicroRNA-204 regulates vascular smooth muscle cell calcification b-glycerophosphate-induced VSMC calcification. ALP is a prophase (proliferative phase) marker of osteoblast differentiation, which increases with cell differentiation. Osteocalcin is a metaphase (bone matrix formation period) marker of osteoblast differentiation. Inhibition of miR-204 promoted osteogenic transdifferentiation and calcification of VSMCs, as indicated by increased levels of ALP activity, osteocalcin secretion, and Runx2 protein expression. In contrast, overexpression of miR-204 attenuated VSMC calcification. These results indicate that miR-204 inhibits VSMC calcification in vitro.
miRNAs regulate gene expression through sequence-specific base pairing of the 'seed region'(bases 2-7) at the 5 ′ of the miRNA with the 3 ′ -UTR-binding sites of mRNA targets. 34 -37 Runx2 has been identified as a key transcription factor for osteoblastic differentiation of precursor cells. 38, 39 It plays an essential role in the osteogenic transdifferentiation as well as in the calcification of VSMCs induced by hydrogen peroxide 40 and uremic serum. 41 Knockdown of Runx2 significantly inhibits the ALP expression and the calcification in the senescent VSMCs. Since miR-204 has been found to inhibit VSMC calcification in vitro, it may also participate in the regulation of vascular calcification in vivo. We generated mouse models overexpressing miR-204 through iv injection of agomir-204-chemically modified oligonucleotides that up-regulated endogenous miR-204 with high specificity and efficiency. The results showed that overexpressing miR-204 decreased Runx2 protein levels and attenuated medial artery calcification induced by vitamin D 3 . These data suggest that miR-204 inhibits medial artery calcification through down-regulating Runx2 protein expression in vivo.
As miR-204 has been reported to attenuate Runx2 protein accumulation during osteoblast differentiation and impede bone formation, 42 we analysed the effect of agomir-204 on BMD and the bone formation parameters of vitamin D 3 -treated mice. However, neither agomir-204 nor vitamin D 3 treatment showed any effect on bone metabolism. A possible explanation for this phenomenon is that 3 days of treatment is too short a period for agomir-204 or vitamin D 3 to cause structural changes on bone.
In conclusion, this study identified miR-204 as an important regulator of VSMC functions by repressing its target gene Runx2 and inhibiting medial artery calcification in vivo, which represents a novel mechanism regulating vascular calcification. This finding provides extensive significance for the prevention and treatment of a variety of cardiovascular disease related to vascular calcification. Investigation of miRNAs in VSMCs and their functions will lead us to a better understanding of their vivo mechanisms and development of miRNA drugs designed against specific gene targets for the treatment of cardiovascular diseases.
